Improved virological outcome in White patients infected with HIV-1 non-B subtypes compared to subtype B
Options
BORIS DOI
Publisher DOI
PubMed ID
21998284
Description
Antiretroviral compounds have been predominantly studied in human immunodeficiency virus type 1 (HIV-1) subtype B, but only ~10% of infections worldwide are caused by this subtype. The analysis of the impact of different HIV subtypes on treatment outcome is important.
Date of Publication
2011
Publication Type
Article
Language(s)
en
Contributor(s)
Scherrer, Alexandra U | |
Ledergerber, Bruno | |
von Wyl, Viktor | |
Böni, Jürg | |
Yerly, Sabine | |
Klimkait, Thomas | |
Bürgisser, Philippe | |
Hirschel, Bernard | |
Cavassini, Matthias | |
Elzi, Luigia | |
Vernazza, Pietro L | |
Bernasconi, Enos | |
Held, Leonhard | |
Günthard, Huldrych F | |
Swiss HIV Cohort, Study |
Additional Credits
Universitätsklinik für Infektiologie
Series
Clinical infectious diseases
Publisher
Oxford University Press
ISSN
1058-4838
Access(Rights)
open.access